Antibodies In-Depth Focus 2017

Posted: 15 March 2017 | | No comments yet

Lone Friis and David Matthews discuss developability assessment of therapeutic antibodies, and Negin Mokhtari and colleagues explain nanoparticle-mediated enzyme delivery for application in cancer therapy…

digital issue #1 2017 in-depth focus antibodies

Included in this Antibodies In-Depth Focus:

  • Developability assessment of therapeutic antibodies
    Lone Friis and David Matthews – MRC Technology Centre for Therapeutics Discovery
  • Antibody-based immunooncology: hopes and perils
    Ismael Samudio, The Centre for Drug Research and Development (CDRD) and Gregorio Aversa, Immcure Theraputics

This Antibodies In-Depth Focus is restricted - login or subscribe free to access

Screening the future innovations in drug discoveryThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here